Pharma Journalist -

Medivir has reported positive data from its phase II clinical trial of the topical, skin-directed histone deacetylase (HDAC) inhibitor, remetinostat, in early stage Cutaneous T-cell…
Read More...

No group of stakeholders wields greater influence over patient access to medicines than payers making reimbursement and formulary decisions. Even in a time of policy upheaval in …
Read More...

IBM announced that its scientists have been granted a patent on machine learning models to predict therapeutic indications and side effects from various drug information sources. IBM…
Read More...

Jazz Pharmaceuticals plc announced that certain of its subsidiaries have entered into agreements with Hikma Pharmaceuticals PLC and related entities ("Hikma") resolving patent…
Read More...

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense…
Read More...

Ligand Pharmaceuticals announced that it has entered into commercial License and Supply Agreements (License Agreement) with Marinus Pharmaceuticals, Inc., granting rights to use…
Read More...

Medidata and clinical-stage pharmaceutical company Karyopharm Therapeutics announced an expanded partnership to bring novel machine-learning technology and targeted risk-based…
Read More...

Delta Marketing Dynamics (DMD) announces the release of "The Current State of Specialty Pharmacy: Challenges and Opportunities", a whitepaper based on the analysis of executive-level…
Read More...

Amcor announces the appointment of Michael Zacka to the new role of Chief Commercial Officer (CCO), effective 1 July 2017.
Read More...

Sanofi announced the appointment of Bill Sibold as VP and Member of Executive Committee of Sanofi Genzyme effective from July 1,2017, after the retirement of David Meeker. Mr.…
Read More...